Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Clinical Study on the Tolerability of Utidelone Capsule in Patients With Advanced Solid Tumors

NCT05681000 is registered in ClinicalTrials.gov with Biostar Pharma, Inc. as lead sponsor.

NCT NCT05681000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05681000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Clinical Study on the Tolerability of Utidelone Capsule in Patients With Advanced Solid Tumors
Lead sponsor
Biostar Pharma, Inc.
Phase
Phase 1
Overall status
Unknown status
Start date
June 9, 2023
Completion date
December 31, 2024
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumor